Plasma serotonin concentrations: validation of a sampling technique using long catheters.

Area of Science:

• Cardiology
• Biochemistry
• Medical Technology

Background:

• Serotonin, released by platelets, may contribute to ischemic syndromes by promoting platelet aggregation and coronary artery constriction.
• The role of serotonin in human ischemic heart disease remains understudied.
• Accurate measurement of transcardiac serotonin metabolism is hindered by potential artifactual changes from platelet activation within catheters.

Purpose of the Study:

• To determine if serotonin can be accurately measured in blood samples obtained through long catheters without artifactual changes.
• To validate a method for assessing transcardiac serotonin metabolism in humans.

Main Methods:

• Paired blood samples were collected from the femoral vein of 13 patients using both a steel needle and a 100-cm polyurethane catheter.
• Samples were processed to obtain platelet-poor plasma.
• Plasma serotonin concentrations were analyzed using a sensitive radioenzymatic assay.

Main Results:

• Blood sampling through long catheters did not induce systematic alterations in plasma serotonin concentration.
• Mean serotonin concentration via needle: 22.3 +/- 26.55 ng/ml; via catheter: 20.0 +/- 26.29 ng/ml (p = 0.34).
• No significant difference was observed between the two sampling methods.

Conclusions:

• Careful blood sampling through long catheters does not significantly alter plasma serotonin concentration.
• Accurate measurement of transcardiac serotonin concentrations is feasible using these methods.
• This validates a technique for studying serotonin's role in human ischemic heart disease.